Taiwan eyes opportunities in precision medicine industry

Taiwan’s biotech and pharmaceutical industry was one of the first to be named in the original Tsai Administration’s 5+2 economic policy to transform the nation’s economic structure, and is viewed as the upcoming medical treatment trend that Taiwan cannot miss out on, said Johnsee Lee, the Honorary Chairman of Taiwan Bio Industry Organization (Taiwan BIO) during the Precision Medicine Industry Forum 2017 in Taipei, Wednesday.

Read more

Revamping healthcare for a changing world

By Tim Ferry
In just 24 years, between 1993 and the end of 2017, Taiwan will have gone from an “aging population” with some 7% of the population 65 years old or older to an “aged society” with 14% of its population elderly. This same demographic shift took 125 years in France, over 40 years in the United States, and even 25 years in the world’s grayest society, Japan. Further, by 2025, one in five Taiwanese will be 65 years old or older, putting Taiwan in the ranks of the super-aged societies.

Read more